Ceribell (CBLL) EBT Margin (2023 - 2026)
Ceribell posted quarterly EBT Margin of 74.5% for Q1 2026, down 1214.0% year-on-year from 6.69% in Q1 2025, and down 36.49% on a QoQ basis from 54.58% in Q4 2025.
Ceribell (CBLL) has 4 years of EBT Margin data on file, last reported at 74.5% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 1214.0% year-over-year to 74.5%; the trailing twelve-month figure through Mar 2026 stood at 63.51% (down 100.0% YoY), and the FY2025 full-year result was 59.97%, up 185.0% from the prior year.
- EBT Margin for Q1 2026 stood at 74.5%, down from 54.58% in the prior quarter.
- Across five years, EBT Margin topped out at 54.58% in Q4 2025 and bottomed at 74.5% in Q1 2026.
- The 4-year median for EBT Margin is 60.75% (2023), against an average of 62.29%.
- The widest annual swing landed in 2025, when EBT Margin surged 1327 bps; it then plunged 1214 bps in 2026.
- A 4-year view of EBT Margin shows it stood at 63.01% in 2023, then dropped by 8 bps to 67.85% in 2024, then climbed by 20 bps to 54.58% in 2025, then tumbled by 36 bps to 74.5% in 2026.
- The last three EBT Margin figures came in at 74.5% (Q1 2026), 54.58% (Q4 2025), and 59.61% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Ceribell | 666.26 Mn | 525.07 Mn | 23.12 Mn | -74.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.50% |
| Dec 31, 2025 | -54.58% |
| Sep 30, 2025 | -59.61% |
| Jun 30, 2025 | -64.36% |
| Mar 31, 2025 | -62.35% |
| Dec 31, 2024 | -67.85% |
| Sep 30, 2024 | -60.58% |
| Jun 30, 2024 | -58.38% |
| Mar 31, 2024 | -59.17% |
| Dec 31, 2023 | -63.01% |
| Sep 30, 2023 | -60.75% |